Zacks Research Forecasts Avantor’s Q3 Earnings (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR) – Equities researchers at Zacks Research lowered their Q3 2026 earnings per share (EPS) estimates for shares of Avantor in a research note issued on Tuesday, March 25th. Zacks Research analyst D. Dey now anticipates that the company will post earnings per share of $0.27 for the quarter, down from their previous forecast of $0.29. The consensus estimate for Avantor’s current full-year earnings is $1.06 per share. Zacks Research also issued estimates for Avantor’s FY2026 earnings at $1.13 EPS and FY2027 earnings at $1.33 EPS.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the previous year, the business earned $0.22 earnings per share.

Several other brokerages have also weighed in on AVTR. Wells Fargo & Company lowered their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Cowen reissued a “buy” rating on shares of Avantor in a research note on Tuesday, March 18th. Royal Bank of Canada dropped their price objective on Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research note on Monday, February 10th. Morgan Stanley reduced their price objective on Avantor from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Monday, February 10th. Finally, Raymond James reissued an “outperform” rating and issued a $24.00 target price (down previously from $26.00) on shares of Avantor in a report on Monday, February 10th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $25.50.

Avantor Stock Performance

NYSE:AVTR opened at $16.17 on Thursday. The firm’s fifty day simple moving average is $18.52 and its 200-day simple moving average is $21.49. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. The stock has a market cap of $11.01 billion, a PE ratio of 15.55, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. Avantor has a fifty-two week low of $15.37 and a fifty-two week high of $28.00.

Institutional Investors Weigh In On Avantor

A number of institutional investors have recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after purchasing an additional 625 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC raised its position in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after purchasing an additional 1,067 shares during the period. UMB Bank n.a. lifted its stake in shares of Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after purchasing an additional 1,074 shares in the last quarter. Finally, AlphaQuest LLC purchased a new stake in shares of Avantor in the fourth quarter worth about $65,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Transactions at Avantor

In other news, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the sale, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP James Bramwell sold 3,758 shares of the company’s stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.50% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.